Revance Therapeutics (NQ: RVNC )
2.820
-0.150
(-5.05%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Press Releases about Revance Therapeutics![]() ![]() Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Revance Announces Proposed Public Offering of Common Stock
March 04, 2024
Via Business Wire
![]() ![]() ![]()
Revance to Participate in Upcoming Investor Conferences
February 21, 2024
Via Business Wire
![]() ![]() Via Business Wire
![]() ![]() ![]()
Revance Appoints Erica Jordan as Chief Commercial Officer, Aesthetics
November 08, 2023
Via Business Wire
![]()
Revance to Participate in Upcoming Investor Conferences
November 06, 2023
Via Business Wire
![]() ![]() ![]()
Revance Provides Corporate Update at Investor Day
September 19, 2023
Via Business Wire
![]()
Revance to Host Investor Day on September 19, 2023
August 22, 2023
Via Business Wire
![]() ![]() ![]() ![]() Via Business Wire
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|